Article Information
History
- August 16, 2022.
Article Versions
- Version 1 (August 3, 2022 - 11:45).
- Version 2 (August 5, 2022 - 07:43).
- Version 3 (August 12, 2022 - 07:37).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonathon W. Senefeld1,#,
- Massimo Franchini2,
- Carlo Mengoli2,
- Mario Cruciani2,
- Matteo Zani2,
- Ellen K. Gorman1,
- Daniele Focosi3,
- Arturo Casadevall4 and
- Michael J Joyner1
- 1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA
- 2Division of Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy
- 3North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy
- 4Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD, USA
- ↵#corresponding author: Senefeld.Jonathon{at}mayo.edu
Author contributions: J.W.S. and M.Z. performed literature searches; C.M. and M.C. performed statistical analyses; M.F. and D.F. wrote the first draft; A.C. and M.J.J. revised the final version.
Posted August 16, 2022.
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review
